AGP Picks
View all

Health & Wellness Today New York
Provided by AGP

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 20, 2026

Regional Health Properties Reports First Quarter 2026 Results
May 20, 2026

Regional Health Properties Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
May 20, 2026

New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization

Indeterminate GlobeNewswire
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
May 20, 2026

BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent

Indeterminate GlobeNewswire
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
May 20, 2026

Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA

Indeterminate GlobeNewswire
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
May 20, 2026

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity

Indeterminate GlobeNewswire
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
May 20, 2026

PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference

Indeterminate GlobeNewswire
Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
May 20, 2026

Stablecoin Development Corporation Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
May 20, 2026

PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million

Indeterminate GlobeNewswire
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
May 20, 2026

Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

Indeterminate GlobeNewswire
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
May 20, 2026

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants

Indeterminate GlobeNewswire
Lung Health Foundation Says Canada’s Current Access System to Emerging Therapies is Moving Slower than Modern Medicine
May 20, 2026

Lung Health Foundation Says Canada’s Current Access System to Emerging Therapies is Moving Slower than Modern Medicine

Indeterminate GlobeNewswire
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
May 20, 2026

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform
May 20, 2026

Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform

Indeterminate GlobeNewswire
Why Biotech Companies Are Replacing National Gas Suppliers With Agile Regional Partners in 2026
May 20, 2026

Why Biotech Companies Are Replacing National Gas Suppliers With Agile Regional Partners in 2026

Indeterminate GlobeNewswire
NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting
May 20, 2026

NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting

Indeterminate GlobeNewswire
BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid 
May 20, 2026

BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid 

Indeterminate GlobeNewswire
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update
May 20, 2026

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update

Indeterminate GlobeNewswire
ZoomRx launches Sagan Agents, the AI operating system purpose-built to agentify any pharma customer insights workflow
May 20, 2026

ZoomRx launches Sagan Agents, the AI operating system purpose-built to agentify any pharma customer insights workflow

Indeterminate GlobeNewswire
Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa
May 20, 2026

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer’s Clinical Trial at 2nd NovaScan Location Planned for Tampa

Indeterminate GlobeNewswire
Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders
May 20, 2026

Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health & Wellness Today New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.